摘要
目的:探讨激素替代治疗(HRT)方案对绝经后妇女乳腺密度的影响。方法:113例绝经后妇女分为4组:①组1 每天口服结合型雌激素(CE)0.625 mg和安宫黄体酮(MPA)4.000 mg;②组2 每天口服 CE 0.625 mg和MPA 2.000 mg;③组3 隔日口服7-甲异炔诺酮2.500 mg;④组4 每天口服CE 0.625 mg(子宫切除者)。服药前和服药后6个月由放射科医师进行乳房X线检查,乳腺密度采用Wolfe标准分类。结果:组1、组2的乳房相密度增加分别为33.3%和25.8%,明显高于组3(8%)和组4(10.5%);组1乳房相增加也明显高于组2(P<0.05)。结论:不同的HRT方案对乳腺显示不同的作用效果。结合雌孕激素治疗比单用CE和7-甲异炔诺酮有较高的危险性;应用低剂量HRT方案和7-甲异炔诺酮对某些病人可能较为有利。
Objective: To evaluate the effect of different hormone replacement therapy (HRT) regimens on mammographic density in postmenopausal women. Methods: One hundred and thirteen patients were divided into 4 groups: (D group 1 was given conjugated estrogen (CE) 0. 625 mg plus medroxyprogesterone acetate (MPA) 4 mg every day; (2) group 2 was given CE 0. 625 mg plus MPA 2 rag every day; ?group 3 was given OrgOD 14 2. 5 mg every two days; @ group 4 was given only CE 0. 625 mg every day. Mammography was taken and analyzed by independent radio-logist blinded to HRT regimens before and 6 months after administration. Mammographic density wasclassified according to Wolfe criteria. Results: The mammographic density increased was much higher in group 1 (33. 3% ) and group 2 (25. 8% ) than that in group 3 (8% ) or group 4 (10. 5% ) . And the increase of mammographic density of group 1 was significantly higher than that of group 2( P < 0. 05). Conclusion: Different HRT regimens have different effects on the breast. There is a higher risk an increase in breast density with combined estrogen-progestogen treatment than with estrogen alone and OrgOD 14. Lower dose of progestogen may have some benefit and OrgOD14 may be another alternative in some patients.
出处
《南京医科大学学报(自然科学版)》
CAS
CSCD
北大核心
2003年第6期615-616,共2页
Journal of Nanjing Medical University(Natural Sciences)
关键词
激素替代治疗
乳房相
乳腺密度
hormone replacement therapy
mammography
breast density